EVOCA™ is our first product, demonstrating the potency of our AGROBODY™ technology to develop new and sustainable tools for growers to protect crops.
EVOCA received regulatory approval by the U.S. EPA in December 2025. It is the first protein-based biofungicide of its kind to be approved by the EPA and a validation of our technology and platform.
Bridging the gap between biological safety and chemical performance in spray rotation programs
EVOCA™ demonstrates a biological-like clean safety profile, while aiming to offer conventional chemical-like performance and consistency when used as per label recommendation in a spray rotation program, thereby addressing a key shortcoming of most current biological crop protection products.
The AGROBODY™ technology platform enables the identification of novel modes of action, as confirmed by the new class assigned by the Fungicide Resistance Action Committee (FRAC) for the active substance of EVOCA™, targeting key plant pathogens in grapes and other high-value crops.
EVOCA™, a new and unique mode of action
EVOCA™’s features and advantages
EVOCA is now EPA approved!
Awards and Recognition
AgTech Breakthrough Award for Sustainable Crop Protection Company of the Year 2024
Awards and Recognition
EVOCA wins World BioProtection Award 2022 for Best BioFungicide Product
EVOCA™, Biotalys’ first biofungicide, won bronze at the 2024 Bernard Blum Awards granted by the International Biocontrol Manufacturers Association (IBMA). These awards are presented annually to the most innovative biocontrol products of the year. The winning products should have a high impact in the management of pests or diseases whilst having a low impact on human health and the environment.